1. Home
  2. QXO vs HOLX Comparison

QXO vs HOLX Comparison

Compare QXO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QXO Inc.

QXO

QXO Inc.

HOLD

Current Price

$17.84

Market Cap

16.3B

Sector

Technology

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QXO
HOLX
Founded
1988
1985
Country
United States
United States
Employees
7794
N/A
Industry
EDP Services
Medical Electronics
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
16.9B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
QXO
HOLX
Price
$17.84
$76.02
Analyst Decision
Strong Buy
Hold
Analyst Count
14
13
Target Price
$32.85
$77.89
AVG Volume (30 Days)
16.7M
95.4M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
$4,100,500,000.00
Revenue This Year
$70.27
$4.74
Revenue Next Year
$38.75
$5.03
P/E Ratio
N/A
$96.23
Revenue Growth
N/A
1.74
52 Week Low
$15.27
$53.62
52 Week High
$27.61
$76.07

Technical Indicators

Market Signals
Indicator
QXO
HOLX
Relative Strength Index (RSI) 35.37 69.09
Support Level $15.75 $75.10
Resistance Level $19.68 N/A
Average True Range (ATR) 0.97 0.19
MACD -0.29 0.03
Stochastic Oscillator 0.45 95.19

Price Performance

Historical Comparison
QXO
HOLX

About QXO QXO Inc.

QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: